Vaccine preventable diseases in returned international travelers Results from the GeoSentinel Surveillance Network

Tropical Disease Unit, UHN-Toronto General Hospital, 200 Elizabeth Street, North Wing, Toronto, ON, M5G 2C4, Canada.
Vaccine (Impact Factor: 3.49). 10/2010; 28(46):7389-95. DOI: 10.1016/j.vaccine.2010.09.009
Source: PubMed

ABSTRACT Vaccine preventable diseases (VPDs) threaten international travelers, but little is known about their epidemiology in this group. We analyzed records of 37,542 ill returned travelers entered into the GeoSentinel Surveillance Network database. Among 580 (1.5%) with VPDs, common diagnoses included enteric fever (n=276), acute viral hepatitis (n=148), and influenza (n=70). Factors associated with S. typhi included VFR travel (p<0.016) to South Central Asia (p<0.001). Business travel was associated with influenza (p<0.001), and longer travel with hepatitis A virus (p=0.02). 29% of those with VPDs had pre-travel consultations. At least 55% of those with VPDs were managed as inpatients, compared to 9.5% of those with non-VPDs. Three deaths occurred; one each due to pneumococcal meningitis, S. typhi, and rabies. VPDs are significant contributors to morbidity and potential mortality in travelers. High rates of hospitalization make them an attractive target for pre-travel intervention.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To define the practice of travel medicine, provide the basics of a comprehensive pretravel consultation for international travelers, and assist in identifying patients who might require referral to travel medicine professionals. Guidelines and recommendations on travel medicine and travel-related illnesses by national and international travel health authorities were reviewed. MEDLINE and EMBASE searches for related literature were also performed. Travel medicine is a highly dynamic specialty that focuses on pretravel preventive care. A comprehensive risk assessment for each individual traveler is essential in order to accurately evaluate traveler-, itinerary-, and destination-specific risks, and to advise on the most appropriate risk management interventions to promote health and prevent adverse health outcomes during travel. Vaccinations might also be required and should be personalized according to the individual traveler's immunization history, travel itinerary, and the amount of time available before departure. A traveler's health and safety depends on a practitioner's level of expertise in providing pretravel counseling and vaccinations, if required. Those who advise travelers are encouraged to be aware of the extent of this responsibility and to refer all high-risk travelers to travel medicine professionals whenever possible. Copyright© the College of Family Physicians of Canada.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Andere Länder, andere Viren und Erkrankungen: In einer Zeit des Massentourismus auch in eher entlegene Gegenden muss vor einer geplanten Reise die genaue Impfsituation eines Patienten abgefragt werden. Welche Impfungen unbedingt sein müssen bzw. zu welchen Sie raten sollten, erfahren Sie im folgenden Beitrag.
    MMW Fortschritte der Medizin 10/2012; 154(18):66-73. DOI:10.1007/s15006-012-1283-9
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Immunocompromised patients are traveling at increasing rates. Physicians caring for these complex patients must be knowledgeable in pretravel consultation and recognize when referral to an infectious disease specialist is warranted. This article outlines disease prevention associated with international travel for adults with human immunodeficiency virus, asplenia, solid organ and hematopoietic transplantation, and other immunosuppressed states. While rates of infection may not differ significantly between healthy and immunocompromised travelers, the latter are at greater risk for severe disease. A thorough assessment of these risks can ensure safe and healthy travel. The travel practitioners' goal should be to provide comprehensive risk information and recommend appropriate vaccinations or prevention measures tailored to each patient's condition. In some instances, live vaccines and prophylactic medications may be contraindicated.
    Therapeutics and Clinical Risk Management 01/2015; 11:217-28. DOI:10.2147/TCRM.S52008 · 1.34 Impact Factor

Full-text (2 Sources)

Available from
May 30, 2014